Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Calithera Biosciences: UCSF Spin-out Takes $40 Million First Round

Jul 01 2010

• By Paul Bonanos

Related Content

Biotech Backers Are Learning to Live with Exit-by-Earn-out

Mar 01 2010

Cadence, VCs Relieve J&J's Pain, Map Out A Clever Exit In The Process

Jul 01 2010

Related Companies

Calithera Biosciences, Inc.

University of California San Francisco

Johnson & Johnson

Johnson & Johnson

Proteolix

Onyx Pharmaceuticals, Inc.

Merck & Co., Inc.

Pfizer Inc.

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window